A Clinical Study to Assess Efficacy and Tolerability of a Topical Skincare Product on Adults With Mature, Crepey Skin
Completed · Phase 4 · NCT07398989
Conditions: Crepey Skin, Aging Skin, Photo-aged Skin
At a glance
- Research payments reported, 2025
- $75,975
- U.S. investigators named
- 2
- Sites paid
- 2
- Planned or actual enrollment
- 32
About the trial
- Sponsor
- Galderma R&D
- Tested
- Cetaphil (drug)
- Dates
- Started 2025-08-12; completion 2026-03-25
- Results posted
- Not yet
Subjects having mild-to-moderate crepiness, photodamage, and loss of firmness will apply a topical skincare regimen to the knees, thighs, hands, and all over the body. Evaluations of the regimen's efficacy will be conducted at 4 weeks, 8 weeks, and 12 weeks post-baseline.
From ClinicalTrials.gov, last updated 2026-04-15. Full record, eligibility and contacts (opens in a new tab)
Industry funding
Galderma Laboratories, L.P. reported $75,975 in research payments for this study in 2025 (4 payments).
Research payments usually go to hospitals, universities and research sites to run a study, not to the investigators personally. A payment is not evidence of wrongdoing.
U.S. investigators named on this study
- Glynis R. Ablon, M.D. Dermatology · Manhattan Beach, CA
- Todd E. Schlesinger, M.D. Dermatology · Charleston, SC
Clinicians the company named as principal investigators in its Open Payments reports.
Sites paid to run it
- Conash Or Inc $64,975
- Clinical Research Center of the Carolinas LLC $11,000
Sources: CMS Open Payments research payments (program year 2025) and ClinicalTrials.gov, U.S. National Library of Medicine.